Komori
Other Disclosures4563AnGes,Inc.Pharmaceuticals

Notice of Selection as a TOPIX Next-tier Constituent

The Company's shares have been selected as a constituent of the TOPIX Next-tier stock index calculated by JPX Market Innovation & Research, Inc. and are scheduled to be included effective 30 October 2026.

Worth reading
43Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Announced details

TOPIX Next-tier
Applicable field (uses covered by this announcement)

Stock indices and investable securities

Launch date30 October 2026 (scheduled; inclusion in the index)
Relationship between the counterparty and the company
AnGes,Inc.4563
Relationship with the Company

The Company is related to JPX Market Innovation & Research, Inc. in that its shares have been selected as constituents of a stock index calculated by the company. No capital or personnel relationship is stated.

CounterpartyJPX Market Innovation & Research, Inc.

JPX Market Innovation & Research, Inc., which calculates TOPIX Next-tier. The index comprises stocks listed on the Tokyo Stock Exchange that meet certain criteria, including liquidity and market capitalization.

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

JPX Market Innovation & Research, Inc.

Announced details
ItemDetails
Names of Products / Services CoveredTOPIX Next-tier
CounterpartyJPX Market Innovation & Research, Inc.
Counterparty overviewJPX Market Innovation & Research, Inc., which calculates TOPIX Next-tier. The index comprises stocks listed on the Tokyo Stock Exchange that meet certain criteria, including liquidity and market capitalization.
Relationship with the CompanyThe Company is related to JPX Market Innovation & Research, Inc. in that its shares have been selected as constituents of a stock index calculated by the company. No capital or personnel relationship is stated.
Launch date30 October 2026 (scheduled; inclusion in the index)
Applicable areaStock indices and investable securities
SourceJPX Market Innovation & Research, Inc.
Items this document does not state (11)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company believes that this selection will contribute to greater market recognition and liquidity for its shares.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Selection as a TOPIX Next-tier Constituent | AnGes,Inc. (4563) timely disclosure | Komori